China Universal Asset Management Co. Ltd. increased its stake in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 10.6% in the fourth quarter, according to the company in its most recent ...

Morgan Stanley raised the firm’s price target on Sana Biotechnology (SANA) to $12 from $9 and keeps an Overweight rating on the shares. Based on the recent type one diabetes update, the firm ...

We came across a bullish thesis on Sana Biotechnology, Inc. (SANA) on wallstreetbets Subreddit Page by Intrepid_Web5454. In ...

NASDAQ:SANA opened at $3.66 on Wednesday. The firm has a market capitalization of $817.16 million, a price-to-earnings ratio of -2.61 and a beta of 1.45. The business has a 50 day simple moving ...

In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA) stands against the other smid-cap stocks. As the name suggests, smid-cap stocks have a valuation ...

Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Sana Biotechnology (SANA – Research Report) yesterday and set a price target of $7.00. The company’s shares closed ...

Last week, Sana Biotechnology, a once-mysterious and still-buzzy biotech startup, released clinical trial results showing that it had managed to implant insulin-producing cells in the arm muscle ...

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA) stands against the other smid ...